Evercore ISI analyst Gavin Clark-Gartner initiated coverage with a Buy rating on Mirum Pharmaceuticals (MIRM – Research Report) today and ...

In this article, we will discuss the 12 High Growth Large Cap Stocks to Buy Now. BlackRock highlighted that its portfolio ...

Clinical development and trial testing of vesleteplirsen (SRP-5051) for Duchenne muscular dystrophy (DMD) was stopped, with ...

Overview: ALSO Holding AG is a technology services provider for the ICT industry, operating in Switzerland, Germany, the Netherlands, Poland, and internationally with a market capitalization of ...

Overview: Bolloré SE operates in transportation and logistics, communications, and industry sectors across various regions including France, Europe, the Americas, Asia, Oceania, and Africa with a ...

In the wake of recent U.S. elections, global markets have experienced notable shifts, with major benchmarks like the S&P 500 and Russell 2000 showing impressive gains as investors anticipate potential ...

The group was led by Casdin Capital, which surged 16 percent last month, according to an investor. This puts its share class that invests only in public securities up more than 40 percent for the year ...

To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future". Sarepta Therapeutics has an accrual ratio of 0.79 for the year to September 2024.

In recent weeks, global markets have experienced significant movements, with U.S. stocks rallying on growth and tax hopes ...

Tesla stock is on a winning streak, up for five consecutive days coming into Tuesday’s trading. Shares are down early as ...

A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...